| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 208,995,000 | 262,394,000 | 202,864,000 | | Cost of Revenue | 187,884,000 | 214,795,000 | 162,883,000 | | | Gross Profit | 21,111,000 | 47,599,000 | 39,981,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 25,804,000 | 24,938,000 | 21,017,000 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (4,693,000) | 22,661,000 | 18,964,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (535,000) | 2,125,000 | 1,636,000 | | Earnings Before Interest And Taxes | (5,228,000) | 24,786,000 | 20,600,000 | | Interest Expense | 477,000 | 460,000 | 418,000 | | Income Before Tax | (5,705,000) | 24,326,000 | 20,182,000 | | Income Tax Expense | (575,000) | 9,098,000 | 7,609,000 | | Minority Interest | 247,000 | (778,000) | (421,000) | | | | Net Income From Continuing Ops | (4,448,000) | 17,146,000 | 13,927,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (4,448,000) | 17,146,000 | 13,927,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,448,000) | $17,146,000 | $13,927,000 |
|
0.29% Nasdaq 
Income Statement
